The MPS Payer Relations Committee is collecting information from members about required prior authorization for generics, with the goal of showing insurance companies that it does not reduce costs.  The information needed is the pharmacy management company, insurance company, medication, and why the prior authorization is needed. Please email the information to Laura Gaffney, M.D., Co-Chair.

The committee also wants members to be aware of the step therapy law, which states that if a patient has been stable on a certain medicine for 3 months and the patient changes insurance, the insurance company is not allowed to require the patient to fail other medications before being prescribed the current medicine. This does not apply to Medicare D, Medicaid or self-insured employers. Members having problems with step therapy requirements should email  Laura Gaffney, M.D., Co-Chair, for assistance.